MUC1 and fibrosis: In a previous study on a population of 67 COVID survivors [15], median KL-6 was 365 U/ml (IQR 233–493), and the authors concluded that “high KL-6 levels at 12 weeks with persisting CT abnormalities (GGO/fibrosis) is a finding that requires further exploration”.